[Federal Register Volume 79, Number 49 (Thursday, March 13, 2014)]
[Notices]
[Page 14298]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-05507]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Research Triangle Institute

    By Notice dated October 10, 2013, and published in the Federal 
Register on October 25, 2013, 78 FR 64018, Research Triangle Institute, 
Hermann Building East Institute Drive, P.O. Box 12194, Research 
Triangle Park, North Carolina 27709, made application by letter to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Tetrahydrocannabinols (7370), a basic class of 
controlled substance listed in schedule I.
    The company plans to provide small quantities to commercial 
customers for use in preparing test kits, reagents, and reference 
standards.
    The company plans to bulk manufacture a synthetic 
Tetrahydrocannabinol. No other activity for this drug code is 
authorized for this registration.
    No comments or objections have been received. The DEA has 
considered the factors in 21 U.S.C. 823(a) and determined that the 
registration of Research Triangle Institute to manufacture the listed 
basic class of controlled substance is consistent with the public 
interest at this time. The DEA has investigated Research Triangle 
Institute to ensure that the company's registration is consistent with 
the public interest. The investigation has included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history.
    Therefore, pursuant to 21 U.S.C. 823 and in accordance with 21 CFR 
1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic class of controlled substance listed.

    Dated: February 19, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2014-05507 Filed 3-12-14; 8:45 am]
BILLING CODE 4410-09-P